Richard I Steinhart's Net Worth

$551 Thousand

Estimate Recalculated Dec 4, 2024 09:06PM EST

Who is Richard I Steinhart

Richard I Steinhart does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include MANHATTAN PHARMACEUTICALS INC, BioXcel Therapeutics, Inc., Actinium Pharmaceuticals, Inc., MELA SCIENCES, INC. /NY, and ATOSSA THERAPEUTICS, INC..

SEC CIK

Richard I Steinhart's CIK is 0001293789

Past Insider Trading and Trends

2018 was Richard I Steinhart's most active year for acquiring shares with 9 total transactions. Richard I Steinhart's most active month to acquire stocks was the month of February. 2023 was Richard I Steinhart's most active year for disposing of shares, totalling 7 transactions. Richard I Steinhart's most active month to dispose stocks was the month of February. 2013 saw Richard I Steinhart paying a total of $337,092.00 for 235,754 shares, this is the most they've acquired in one year. In 2021 Richard I Steinhart cashed out on 7,500 shares for a total of $180,562.50, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

MANHATTAN PHARMACEUTICALS INC

Investor
Updated Mar 10, 2010
Form 4
300.00K
Mar 10, 2010
521.64K
Grant
Mar 03
Form 4
75.00K
Mar 28, 2008
216.01K
Grant
Mar 25
Form 4
55.63K
Jan 31, 2007
146.64K
Grant
Jan 30
Form 4
11.01K
Feb 22, 2005
91.01K
Grant
Jan 11
Form 4
80.00K
Sep 28, 2004
80.00K
Grant
Sep 27
Form 3
Sep 02, 2004
Showing 6 results

BioXcel Therapeutics, Inc.

Chief Financial Officer
Updated Sep 17, 2024
Form 4
-2.32%
-356.00
$0.69
-$245.60
Sep 17, 2024
14.96K
Sale
ScheduledSep 14 - Sep 16
Form 4
-2.37%
-372.00
$1.26
-$469.54
Jun 18, 2024
15.31K
Sale
ScheduledJun 14 - Jun 17
Form 4
-6.38%
-1.07K
$2.64
-$2.82K
Apr 08, 2024
15.68K
Sale
ScheduledMar 14 - Apr 04
Form 4
Dec 18, 2023
7.75K
Options
Dec 14
Form 4
Sep 18, 2023
7.75K
Options
Sep 14
Form 4
Jun 16, 2023
7.75K
Options
Jun 14
Form 4
-76.92%
-5.00K
$27.17
-$135.86K
May 16, 2023
1.50K
Sale
May 14 - May 15
Form 4
395.61%
38.92K
$19.50
-$40.64K
Mar 16, 2023
48.75K
Sell-Options
ScheduledMar 14 - Mar 15
Form 4
5.00K
May 17, 2022
5.00K
Grant
May 14
Form 4
41.69K
Mar 16, 2022
41.69K
Grant
Mar 14
Form 4
20.00K
Mar 29, 2021
20.00K
Grant
Mar 25
Form 4
-4.39%
-3.75K
$26.85
-$159.75K
Feb 03, 2021
81.65K
Sale
ScheduledFeb 01
Form 4
55.00K
May 28, 2020
55.00K
Grant
May 26
Form 4
50.00%
500.00
$5.20
$2.60K
Dec 04, 2018
1.50K
Purchase
Dec 03
Form 4
100.00%
500.00
$5.00
$2.50K
Nov 30, 2018
1.00K
Purchase
Nov 30
Form 4
500.00
$5.00
$2.50K
Nov 30, 2018
500.00
Purchase
Nov 29
Form 4
38.42%
32.23K
Mar 13, 2018
116.13K
Grant
Mar 12
Form 3
Mar 07, 2018
Showing 18 results

Actinium Pharmaceuticals, Inc.

Investor
Updated Dec 29, 2023
Form 4
70.31K
Dec 29, 2023
70.31K
Grant
Dec 28
Form 4
72.16K
Jul 01, 2022
72.16K
Grant
Jul 01
Form 4
18.35K
Sep 03, 2021
18.35K
Grant
Sep 01
Form 4
8.33K
Aug 14, 2020
8.33K
Grant
Aug 12
Form 4
250.00K
$0.23
$58.00K
Jul 16, 2019
250.00K
Grant
Jul 12
Form 4
75.00K
$0.78
$58.72K
Jul 17, 2018
75.00K
Grant
Jul 13
Form 4
560.00%
14.00K
$0.50
$7.00K
Mar 08, 2018
16.50K
Acquisition
Mar 06
Form 4
75.00K
$1.39
$104.25K
Mar 16, 2017
75.00K
Grant
Mar 14
Form 4
77.50K
$2.00
$154.28K
Apr 18, 2016
77.50K
Purchase
Apr 14 - Apr 15
Form 4
25.00K
$3.58
$89.50K
Mar 16, 2015
25.00K
Grant
Feb 18
Form 4
49.95K
$6.70
$334.67K
Dec 24, 2013
49.95K
Grant
Dec 16
Form 3
Nov 13, 2013
Showing 12 results

MELA SCIENCES, INC. /NY

Chief Financial Officer
Updated Aug 08, 2013
Form 4
181.30K
Aug 08, 2013
181.30K
Grant
Aug 05
Form 4
300.00%
3.00K
$0.81
$2.43K
Jun 25, 2013
4.00K
Purchase
Jun 25
Form 4
1.50K
Apr 26, 2013
1.50K
Grant
Apr 25
Form 4
100.00K
Apr 26, 2011
100.00K
Grant
Apr 25
Form 4
1.00K
$6.32
$6.32K
Aug 12, 2010
1.00K
Purchase
Aug 12
Form 4
16.50K
May 14, 2010
16.50K
Grant
May 13
Form 3
May 02, 2006
Showing 7 results

ATOSSA THERAPEUTICS, INC.

Investor
Updated Jul 01, 2024
Form 4
125.00K
Jul 01, 2024
125.00K
Grant
Jun 27
Form 4
125.00K
May 05, 2023
125.00K
Grant
May 04
Form 4
11.11%
50.00K
May 16, 2022
500.00K
Grant
May 13
Form 4
50.00K
May 18, 2021
50.00K
Grant
May 14
Form 4
45.00K
May 19, 2020
45.00K
Grant
May 15
Form 4
45.00K
May 21, 2019
45.00K
Grant
May 17
Form 4
45.00K
Jun 29, 2018
45.00K
Grant
Jun 27
Form 4
519.68%
49.53K
May 26, 2017
59.06K
Grant
May 24
Form 4
71.48K
May 19, 2016
71.48K
Grant
May 18
Form 4
40.00K
May 14, 2015
40.00K
Grant
May 12
Form 4
-34.00%
-7.73K
May 08, 2014
15.00K
Disposition
May 06
Form 4
39.21K
Mar 04, 2014
39.21K
Grant
Mar 01
Form 3
Mar 04, 2014
Showing 13 results